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occur in the eye and the brain. These neuropathological 
processes ultimately lead to neuronal cell death and include 
ischaemia, inflammation, mitochondrial dysfunction 
The involvement of the retina in CNS disease is increas-
ingly recognized in the area of neurodegeneration, as there 
is accumulating evidence showing that similar mechanisms 
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Fig. 1  Examples of neurode-
generative eye and brain dis-
eases illustrating overlap of key 
neuropathological mechanisms
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(including oxidative stress), deposition of misfolded pro-
teins, and changes in fluid dynamics [aqueous and cerebro-
spinal fluid (CSF)] [1, 5, 6, 9–11].
Although common to some degree in all neurodegenera-
tive conditions, specific events are associated more closely 
with certain diseases. Hence, deposition and aggregation of 
the misfolded proteins alpha-synuclein and beta-amyloid 
are believed to be key in their development in Parkinson’s 
disease (PD) and Alzheimer’s disease (AD), respectively 
[4]; mitochondrial dysfunction is particularly associated 
with LHON (Leber’s Hereditary optic neuropathy) and 
PD [12]; an important element of optic neuritis and LHON 
is inflammation [2, 14]; both optic neuritis and glaucoma 
include an ischemic aetiology [3, 8]; and finally, abnormal 
fluid dynamics is heavily implicated in glaucoma (through 
intraocular pressure) [3] and AD (CSF clearance) [7]. 
These overlaps are illustrated in the Venn diagram above 
(Fig. 1).
This issue of Acta Neuropathologica includes a cluster 
of three review papers on different aspects of neurodegen-
eration involving the retina, from experts in ophthalmol-
ogy, neuro-ophthalmology, and neuroscience and covering 
glaucoma [3], Alzheimer’s disease [7], and LHON [13]. 
In each case, they address the neuropathological mecha-
nisms that highlight why the retina may serve as a valu-
able model to study brain disease. They include molecular 
advances, evidence for commonalities between brain and 
eye changes, cell death processes, and recent updates on 
targets for therapy. Furthermore, they promote the idea that 
due to its accessibility, the eye can be a tool through which 
disease activity and treatment response can be assessed 
with widespread applications for neurological disease. This 
cluster will hopefully be of interest to neuropathologists, 
ophthalmic pathologists, neuroscientists, and neurologists 
intrigued by how and why it might be possible to eye the 
brain.
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